Shivering needed to trigger beneficial metabolic health effects of repeated cold exposure, study suggests
Diabetologia
*note this work will feature in an embargoed press conference at the meeting, see details below*
*press release available in Spanish and Portuguese – see below*
New research, being presented at this year’s European Association for the Study of Diabetes (EASD) Annual Meeting in Stockholm, Sweden (19-23 Sept), finds that shivering during repeated exposure to cold improves glucose tolerance, decreases fasting blood sugar and blood fat levels, and markedly reduces blood pressure in overweight and obese adults.
The preliminary study, by Adam Sellers, Sten van Beek, and colleagues from Maastricht University in The Netherlands, highlights the potential for repeated cold exposure that activates shivering as an alternative strategy to treat and prevent type 2 diabetes (T2D).
Previous research has shown that when humans are cold, glucose is cleared from the blood faster. Brown fat was thought to play a major role in lowering blood glucose and improving insulin sensitivity in humans, thereby helping to reduce insulin resistance and the risk of diseases, including diabetes.
“Brown fat is a metabolic heating system inside our bodies, burning calories”, explains Sellers. “This generates heat and prevents calories from being deposited as normal white fat. Brown fat is activated during cold and when we eat, but its activity is less in older adults and in individuals with obesity and diabetes.”
A previous study demonstrated that 10 days of mild cold acclimation (14 to 15°C, 6 hours per day) markedly improved insulin sensitivity in patients with T2D. But the change in brown fat after cold acclimation was minor and could not explain the large improvement in insulin sensitivity. However, after cold acclimation, glucose transporter 4 (GLUT4) translocation in skeletal muscle was enhanced (during which GLUT4 moves to a more favourable position which facilitates glucose clearance from the blood and into the muscle) [1].
But although non-shivering thermogenesis—which generates heat from stored energy without muscle contraction—is involved in mild cold acclimation, a follow-up study indicated that some level of (mild) muscle activity/shivering may be crucial in activating the beneficial metabolic effects of cold [2].
“When we are cold, we can activate our brown fat because it burns energy and releases heat to protect us. In addition, muscle can contract mechanically, or shivers, thereby generating heat. As there is considerably more muscle than brown fat in a human, shivering can burn more calories and produce more heat”, explains Sellers.
To find out more, researchers exposed volunteers—11 men and 4 postmenopausal women with overweight or obesity (aged 40-75 years, BMI 27-35 kg/m²)—to 10 consecutive days of cold to activate shivering, using a water-perfused suit to control and lower body temperature. Participants were exposed to cold, from 32°C to 10°C, until they shivered for one hour per day.
Shivering was monitored by special devices placed on the skin that sense muscle electrical activity as well as visual observation. The one hour of shivering was started when resting energy expenditure increased by 50% [3].
Before and after the intervention, a 2-hour oral glucose tolerance test (OGTT) was performed under thermoneutral conditions—the environmental temperature where the body does not need to produce heat to maintain its core temperature [4]. Researchers also measured heart rate and blood pressure and took muscle biopsies to determine potential changes in the muscle related to glucose metabolism, such as GLUT4 translocation.
The findings showed that repeated cold-induced shivering significantly reduced average fasting plasma glucose concentrations from 5.84 to 5.67 mmol/L, and improved glucose tolerance by 6% [5].
Plasma insulin concentrations before and during the OGTT were unaffected after the shivering intervention. This suggests the improved fasting glucose and glucose tolerance after repeated shivering were not because of increased insulin in the blood.
Interestingly, fasting plasma triglyceride and free-fatty acid concentrations were markedly reduced by 32% and 11%, respectively. These are the major fat fuels in the body, and are thought to raise the risk of cardiovascular disease and contribute to insulin resistance.
In addition, repeated cold exposure also markedly reduced systolic and diastolic blood pressure by around 10 mmHg and 7 mmHg, respectively, and tended to reduce resting heart rate when measured under thermoneutral conditions.
Surprisingly, muscle GLUT4 translocation was unchanged after the shivering intervention. This suggests that other changes occurred in skeletal muscle, and/or potentially, other organs that explain the improved glucose tolerance.
The authors acknowledge several limitations, including the inability to draw strong causal conclusions about the direct effect of cold exposure on metabolic health. They also note that, despite measures taken to control diet and physical activity, other lifestyle factors, or genetic factors not measured in the current study could impact the findings.
“Nevertheless, this is an important first step investigating the effect of shivering on health. Our findings are promising and may have important health implications, given that shivering improved many cardiometabolic health outcomes which are associated with diseases like type 2 diabetes”, says Sellers. “In future studies, we plan to assess the effect of shivering in adults with type 2 diabetes.”
For interviews with the report authors, please contact Adam Sellers, Maastricht University in The Netherlands E) adam.sellers@maastrichtuniversity.nl T) +44 (0)7708010933
Alternative contact in the EASD Press Room: Tony Kirby T) + 44(0)7834 385827 E) tony@tonykirby.com
The study was funded by ZonMw – The Netherlands Organisation for Health Research and Development.
The authors have no conflicts of interest.
Notes to editors:
[1] Short-term cold acclimation improves insulin sensitivity in patients with type 2 diabetes mellitus
[2] Metabolic responses to mild cold acclimation in type 2 diabetes patients | Nature Communications
[3] Energy expenditure was calculated by measuring the oxygen and carbon dioxide in the exhaled breath of participants. This is important because shivering can vary between individuals even though the cold exposure is the same. Researchers were then able to create a similar shivering response in all individuals using changes in energy expenditure because this measurement includes all muscles shivering in the body.
[4] An OGTT involves having a blood test after not eating or drinking for 8-10 hours. Then a glucose drink is consumed. After resting for two hours, another blood sample is taken to see how the body is dealing with glucose.
[5] The expected values for normal fasting blood glucose concentration are between 70 mg/dL (3.9 mmol/L) and 100 mg/dL (5.6 mmol/L).
This press release is based on abstract 160 at The European Association for the Study of Diabetes (EASD). All accepted abstracts have been extensively peer reviewed by the congress selection committee. There is no full paper at this stage, but the authors are happy to answer your questions. The research has not yet been submitted to a medical journal for publication. As this is an oral presentation no poster is available.
For press release in Spanish, click here
For press release in Portuguese, click here
This work will be part of the EASD embargoed press on zoom taking place at 12.00H noon Stockholm time on Wednesday 21 Sept. To join the Zoom event click the link below at this time.
https://us06web.zoom.us/j/81469655805?pwd=eUcvWkRHQUtXMCs4RTNuaDVCOE1hZz09
The authors declare no conflicts of interest
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.
Media Contact
Judy Naylor
Diabetologia
diabetologia-j@bristol.ac.uk
Office: 44-117-323-5338
Expert Contacts
Adam Sellers
Maastricht University in The Netherlands
adam.sellers@maastrichtuniversity.nl
Cell: +44 7708010933
Tony Kirby
EASD Media Office
tony.kirby@tonykirby.com
Cell: +447834385827
Diabetologia
Copyright © 2022 by the American Association for the Advancement of Science (AAAS)
Copyright © 2022 by the American Association for the Advancement of Science (AAAS)